|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1993-3-2
|
|
pubmed:abstractText |
c-Myc (Myc) and Max proteins dimerize and bind DNA through basic-helix-loop-helix-leucine zipper motifs (b-HLH-LZ). Using a genetic approach, we demonstrate that binding to Max is essential for Myc transforming activity and that Myc homodimers are inactive. Mutants of Myc and Max that bind efficiently to each other but not to their wild-type partners were generated by either exchanging the HLH-LZ domains or reciprocally modifying LZ dimerization specificities. While transformation defective on their own, complementary mutants restore Myc transforming activity when coexpressed in cells. The HLH-LZ exchange mutants also have dominant negative activity on wild-type Myc function. In addition, wild-type max antagonizes myc function in a dose-dependent manner, presumably through competition of Max-Max and Myc-Max dimers for common target DNA sites. Therefore, Max can function as both suppressor and activator of Myc. A general model for the role of Myc and Max in growth control is discussed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0092-8674
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
29
|
|
pubmed:volume |
72
|
|
pubmed:geneSymbol |
c-myc,
max,
myc
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
233-45
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8425220-Amino Acid Sequence,
pubmed-meshheading:8425220-Animals,
pubmed-meshheading:8425220-Base Sequence,
pubmed-meshheading:8425220-Basic Helix-Loop-Helix Leucine Zipper Transcription Factors,
pubmed-meshheading:8425220-Basic-Leucine Zipper Transcription Factors,
pubmed-meshheading:8425220-Cell Line,
pubmed-meshheading:8425220-Cell Transformation, Neoplastic,
pubmed-meshheading:8425220-DNA-Binding Proteins,
pubmed-meshheading:8425220-Exons,
pubmed-meshheading:8425220-Genes, myc,
pubmed-meshheading:8425220-Genetic Vectors,
pubmed-meshheading:8425220-Humans,
pubmed-meshheading:8425220-Leucine Zippers,
pubmed-meshheading:8425220-Macromolecular Substances,
pubmed-meshheading:8425220-Molecular Sequence Data,
pubmed-meshheading:8425220-Mutagenesis, Site-Directed,
pubmed-meshheading:8425220-Protein Binding,
pubmed-meshheading:8425220-Proto-Oncogene Proteins c-myc,
pubmed-meshheading:8425220-Restriction Mapping,
pubmed-meshheading:8425220-Saccharomyces cerevisiae,
pubmed-meshheading:8425220-Transcription, Genetic,
pubmed-meshheading:8425220-Transcription Factors,
pubmed-meshheading:8425220-Transfection
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Oncogenic activity of the c-Myc protein requires dimerization with Max.
|
|
pubmed:affiliation |
Growth Control and Development Laboratory, Imperial Cancer Research Fund, Lincoln's Inn Fields, London, England.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
